Acute Retinal Necrosis: Is The Current Valacyclovir Regimen Adequate?
- PMID: 31401907
- DOI: 10.1080/09273948.2019.1616771
Acute Retinal Necrosis: Is The Current Valacyclovir Regimen Adequate?
Abstract
Acute Retinal Necrosis (ARN) is a potentially devastating form of Uveitis. Antivirals are the mainstay treatment for this syndrome. In this letter, we question the current oral Valacyclovir dosage, based on the experience we had with a recent unresponsive ARN case.
Keywords: Acute retinal necrosis syndrome; antiviral agents; posterior uveitis; retinal detachment; valacyclovir.
Comment in
-
Comment on "Acute Retinal Necrosis: Is the Current Valacyclovir Regimen Adequate?".Ocul Immunol Inflamm. 2022 Jul;30(5):1289. doi: 10.1080/09273948.2020.1860234. Epub 2021 Jan 29. Ocul Immunol Inflamm. 2022. PMID: 33512259 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources